180 Life Sciences Corp (ATNF)
2.24
-0.04
(-1.75%)
USD |
NASDAQ |
Nov 22, 16:00
2.36
+0.12
(+5.36%)
After-Hours: 19:49
180 Life Sciences Shareholders Equity (Quarterly): 3.734M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 3.734M |
| June 30, 2024 | -0.418M |
| March 31, 2024 | -0.9545M |
| December 31, 2023 | -0.1277M |
| September 30, 2023 | -0.1493M |
| June 30, 2023 | 6.716M |
| March 31, 2023 | 7.140M |
| December 31, 2022 | 11.34M |
| September 30, 2022 | 26.08M |
| Date | Value |
|---|---|
| June 30, 2022 | 42.79M |
| March 31, 2022 | 40.90M |
| December 31, 2021 | 39.32M |
| September 30, 2021 | 37.14M |
| June 30, 2021 | 2.716M |
| March 31, 2021 | 22.71M |
| December 31, 2020 | 30.29M |
| December 31, 2019 | 38.57M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.9545M
Minimum
Mar 2024
42.79M
Maximum
Jun 2022
18.11M
Average
11.34M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Seelos Therapeutics Inc | -28.13M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
| Theriva Biologics Inc | 24.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.47M |
| Total Liabilities (Quarterly) | 6.736M |